1. Home
  2. ARQT vs HE Comparison

ARQT vs HE Comparison

Compare ARQT & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • HE
  • Stock Information
  • Founded
  • ARQT 2016
  • HE 1891
  • Country
  • ARQT United States
  • HE United States
  • Employees
  • ARQT N/A
  • HE N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • HE Electric Utilities: Central
  • Sector
  • ARQT Health Care
  • HE Utilities
  • Exchange
  • ARQT Nasdaq
  • HE Nasdaq
  • Market Cap
  • ARQT 1.7B
  • HE 1.9B
  • IPO Year
  • ARQT 2020
  • HE N/A
  • Fundamental
  • Price
  • ARQT $15.00
  • HE $10.57
  • Analyst Decision
  • ARQT Strong Buy
  • HE Hold
  • Analyst Count
  • ARQT 6
  • HE 4
  • Target Price
  • ARQT $18.80
  • HE $10.94
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • HE 1.7M
  • Earning Date
  • ARQT 08-13-2025
  • HE 08-08-2025
  • Dividend Yield
  • ARQT N/A
  • HE N/A
  • EPS Growth
  • ARQT N/A
  • HE N/A
  • EPS
  • ARQT N/A
  • HE N/A
  • Revenue
  • ARQT $212,819,000.00
  • HE $3,171,906,000.00
  • Revenue This Year
  • ARQT $61.15
  • HE $23.08
  • Revenue Next Year
  • ARQT $37.98
  • HE $1.74
  • P/E Ratio
  • ARQT N/A
  • HE N/A
  • Revenue Growth
  • ARQT 100.03
  • HE 0.66
  • 52 Week Low
  • ARQT $7.86
  • HE $8.14
  • 52 Week High
  • ARQT $17.75
  • HE $18.19
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 60.23
  • HE 47.86
  • Support Level
  • ARQT $13.06
  • HE $10.52
  • Resistance Level
  • ARQT $15.36
  • HE $10.85
  • Average True Range (ATR)
  • ARQT 0.66
  • HE 0.32
  • MACD
  • ARQT 0.12
  • HE -0.01
  • Stochastic Oscillator
  • ARQT 82.57
  • HE 22.67

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

Share on Social Networks: